title: Antibiotic treatment of preterm labor with intact membranes: a multicenter, randomized, double-blinded, placebo-controlled trial.
abstract: OBJECTIVE
  Although an association between subclinical intrauterine infection and preterm birth is well established, there is conflicting evidence regarding the benefits of antibiotic administration to women in preterm labor with intact membranes. We attempted to determine the effect of ampicillin-amoxicillin and erythromycin treatment on prolongation of pregnancy, the rate of preterm birth, and neonatal morbidity in patients with preterm labor and intact membranes.
  
  
  METHODS
  A multicenter, randomized, double-blinded, placebo-controlled trial was designed and implemented by the Maternal-Fetal Medicine Units Network of the National Institute of Child Health and Human Development. Two hundred seventy-seven women with singleton pregnancies and preterm labor with intact membranes (24 to 34 weeks) were randomly allocated to receive either antibiotics or placebos.
  
  
  RESULTS
  Of the 2373 patients screened for participation in this study in six medical centers, 277 women were enrolled (n = 133 for antibiotics group vs n = 144 for placebo group). In each study group, 60% of patients completed all the study medications. The overall prevalence of microbial invasion of the amniotic cavity was 5.8% (14/239). No significant difference between the antibiotic group and the placebo group was found in maternal outcomes, including duration of randomization-to-delivery interval, frequency of preterm delivery (< 37 weeks), frequency of preterm premature rupture of membranes, clinical chorioamnionitis, endometritis, and number of subsequent admissions for preterm labor. Similarly, no significant difference in neonatal outcomes could be detected between the two groups including respiratory distress syndrome, bronchopulmonary dysplasia, intraventricular hemorrhage, sepsis, and admission and duration of newborn intensive special care unit hospitalization.
  
  
  CONCLUSIONS
  The results of this study do not support the routine use of antibiotic administration to women in preterm labor with intact membranes.
authors.affiliation: Yale University, New Haven, Connecticut.
authors.forename: R
authors.initials: R
authors.lastname: Romero
authors.forename: B
authors.initials: B
authors.lastname: Sibai
authors.forename: S
authors.initials: S
authors.lastname: Caritis
authors.forename: R
authors.initials: R
authors.lastname: Paul
authors.forename: R
authors.initials: R
authors.lastname: Depp
authors.forename: M
authors.initials: M
authors.lastname: Rosen
authors.forename: M
authors.initials: M
authors.lastname: Klebanoff
authors.forename: V
authors.initials: V
authors.lastname: Sabo
authors.forename: J
authors.initials: J
authors.lastname: Evans
authors.forename: E
authors.initials: E
authors.lastname: Thom
mesh_terms: D000284:Administration, Oral; D000328:Adult; D000658:Amoxicillin / Q000008:administration & dosage / Q000627:therapeutic use*; D000667:Ampicillin / Q000008:administration & dosage / Q000627:therapeutic use*; D016009:Chi-Square Distribution; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D004917:Erythromycin / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D007752:Obstetric Labor, Premature / Q000188:drug therapy*; D010349:Patient Compliance; D011247:Pregnancy; D011256:Pregnancy Outcome; D011262:Pregnancy Trimester, Second; D011263:Pregnancy Trimester, Third; D015145:Tocolysis; D016896:Treatment Outcome
chemical_list: D004917:Erythromycin; D000667:Ampicillin; D000658:Amoxicillin